Ironwood Financial’s Regeneron Pharmaceuticals REGN Stock Holding History

Ironwood Financial’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-170	Closed	-$103K	–	437
2021 Q3	$103K	Buy	170 +60	+55%	+$37.2K	0.03%	140
2021 Q2	$61K	Hold	110	–	–	0.02%	178
2021 Q1	$52K	Sell	110 -125	-53%	-$60.9K	0.02%	173
2020 Q4	$114K	Buy	235 +35	+18%	+$18.9K	0.04%	118
2020 Q3	$112K	Hold	200	–	–	0.06%	79
2020 Q2	$125K	Hold	200	–	–	0.07%	71
2020 Q1	$98K	Hold	200	–	–	0.07%	58
2019 Q4	$75K	Hold	200	–	–	0.03%	87
2019 Q3	$55K	Hold	200	–	–	0.03%	106
2019 Q2	$63K	Hold	200	–	–	0.03%	94
2019 Q1	$82K	Hold	200	–	–	0.04%	85
2018 Q4	$75K	Hold	200	–	–	0.04%	82
2018 Q3	$81K	Buy	+200	New	+$76.1K	0.04%	84

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Ironwood Financial's REGN Position: Q4 2021 in Review

Ironwood Financial sold out of Regeneron Pharmaceuticals (REGN) in Q4 2021, closing a stake of 170 shares — an estimated $103K sold.

Ironwood Financial first reported a position in REGN in Q3 2018 and held it in 13 quarters. The position peaked at $125K in Q2 2020. 1,078 funds tracked by Wall St. Rank hold REGN as of Q4 2021.

Ironwood Financial reported no remaining Regeneron Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
Ironwood Financial sold 170 Regeneron Pharmaceuticals shares in Q4 2021, an estimated $103K.
Ironwood Financial first reported a position in Regeneron Pharmaceuticals in Q3 2018 and held it in 13 quarters.
Ironwood Financial's Regeneron Pharmaceuticals position peaked at $125K in Q2 2020.
1,078 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2021.

Based on Ironwood Financial's 13F filing for Q4 2021, filed 28 Jan 2022.